Key Takeaways: Somai Pharmaceuticals Ltd is redesigning the biopharma industry by leveraging on cannabis-based treatments. Operational in several European countries, Somai Pharma is developing and distributing cannabinoid-containing pharmaceutical products that comply with EU-GMP standards. The company’s current focus is on building scalable extraction facilities
Read MoreThe brand’s first-ever side-by-side redefines the UTV segment with 20 years of motorsports-proven engineering expertise, advanced lightweight construction and OEM-level automotive manufacturing,
The Series A funding takes Vensum Power from technology development to industrial production. First products for EV charging and energy storage are
MassChallenge Switzerland Awards Equity-Free Prizes to High-Impact Startups at 2026 Awards Ceremony Ten early-stage startups share CHF 250,000; NUCAPS and Grain Weevil
Oslo/Berlin, 22 October 2026 – PAIR Finance, Europe’s leading AI debt collection platform, today launches in Norway. The fintech company opens its
New Commentaries library offers free-to-read legal commentary drafted from primary sources using Moonlit’s proprietary AI, reviewed by named legal experts and linked
Central Asia-based platform serves 45,000 users and offers access to more than 13,000 securities across more than 26 stock exchanges worldwide Amsterdam,
VILNIUS, Lithuania — 12 October 2026 — MNP Technologijos, operating under the Monopulse brand, has raised over €2 million from investors in
Prague / London – 9 October 2026 – JSK Investments SICAV a.s., a self-managed investment fund for qualified investors, has participated in
The creative platform unveils a new standard for AI imagery, embedding a professional art direction layer that translates simple prompts into fully-realized
Funding will accelerate US scale-up of EOlife®, a real-time ventilation feedback device designed to improve cardiac arrest resuscitation survival and neurological outcomes.
